Children from around the world have come to Monterrey, Mexico to receive a promising treatment using intra-arterial (IA) chemotherapy and immunotherapy for DIPG–diffuse intrinsic pontine glioma (DIPG).
For many of the children, Monterrey represents their last hope. The treatment has already extended the lives of many of the children receiving it, and their quality of life has also improved dramatically.
Because of the rarity of this disease, parents of DIPG have formed a close cluster, communicating through social media and sharing anything they know to other parents in need. Mexico has been communicated with resounding positivity.
The challenge for America is the location and the fact that American insurance companies don’t cover out-of-country health procedures. For this Mexico trial, the cost of one year of treatment in Monterrey amounts to over $300,000—without accounting for unexpected complications and extended hospital stays.
When parents find something that can help save their child’s life, they’ll stop at nothing to provide it for them.